ALKEM logo

Alkem Laboratories LTD.

F&O
ALKEM·NSE·
5,300.00 -29.50 (-0.55%)
Market Cap63369.45 Cr
PE Ratio27.53
Volume86,598
Day High - Low5358.00 - 5277.00
52W High-Low5933.50 - 5075.00
DocStoX Score
5.3/10
Weak
Fair Value
Sign in to see
ROE
18.90%
Strong
P/E
27.53x
Fair
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 200NIFTY 500NIFTY MIDCAP 150
Day5277
5358
52W5075
5934
DocStoX take

Supported by risk (9.8) and quality (6.9), but held back by momentum (1.6). Risk looks strong at 9.8, but that is offset by momentum at 1.6 and valuation at 2.6. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.3
/10
Weak
Quality
Solid
ROE 18.9%
Valuation
Expensive
P/E 27.5×
Growth
Slow
Revenue +10.7% 5Y CAGR
Risk
Low risk
D/E 0.04
Momentum
Weak
26% of 52-week range

At a glance

Market Cap
₹63,369 Cr
52W High / Low
₹5934 / ₹5075
Dividend Yield
1.00%
Promoter Holding
49.70%
EPS (TTM)
₹192.51
Book Value
₹1156.00

Key highlights

  • Low leverage — D/E 0.04
  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 21%
  • Momentum is weak (1.6/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ALKEM LABORATORIES LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.